Birgit Spänkuch

Trastuzumab-modified nanoparticles: Optimisation of preparation and uptake in cancer cells

I Steinhauser, Birgit Spänkuch, Klaus Strebhardt et al. · Biomaterials · 2006 · 214 citations

Nanoparticles, Nanomedicine, Engineering +8

Stable gene silencing of cyclin B1 in tumor cells increases susceptibility to taxol and leads to growth arrest in vivo

Juping Yuan, Andrea Krämer, Yves Matthess et al. · Oncogene · 2005 · 130 citations

Medicine, Cyclin B1, Stable Gene Silencing +8

Rational combinations of siRNAs targeting Plk1 with breast cancer drugs

Birgit Spänkuch, Elisabeth Kurunci‐Csacsko, M. Kaufmann et al. · Oncogene · 2007 · 96 citations

Rational Combinations, Breast Oncology, Drug Targeting +5

Effect of trastuzumab-modified antisense oligonucleotide-loaded human serum albumin nanoparticles prepared by heat denaturation

I Steinhauser, Klaus Langer, Klaus Strebhardt et al. · Biomaterials · 2008 · 85 citations

Nanoparticles, Heat Denaturation, Engineering +5

Down-regulation of Polo-like Kinase 1 Elevates Drug Sensitivity of Breast Cancer Cells<i>In vitro</i>and<i>In vivo</i>

Birgit Spänkuch, Sandra Heim, Elisabeth Kurunci‐Csacsko et al. · Cancer Research · 2006 · 76 citations